A RATIONAL GUIDE TO ROUTINE BLOOD MONITORING IN PATIENTS RECEIVING ANTIEPILEPTIC DRUGS

被引：92

作者：

PELLOCK, JM ^{[1
]}

WILLMORE, LJ ^{[1
]}

机构：

[1] UNIV TEXAS,SCH MED,DEPT NEUROL,HOUSTON,TX 77025

来源：

关键词：

HEPATIC-FAILURE; VALPROATE; CHILDREN; THERAPY; CARBAMAZEPINE; LIVER;

D O I：

10.1212/WNL.41.7.961

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：961 / 964

页数：4

共 26 条

[11] MARKEDLY INCREASED OMEGA-OXIDATION OF VALPROATE IN FULMINANT HEPATIC-FAILURE
KUHARA, T
INOUE, Y
MATSUMOTO, M
SHINKA, T
MATSUMOTO, I
KAWAHARA, N
SAKURA, N
[J]. EPILEPSIA, 1990, 31 (02) : 214 - 217
[12] KUTT H, 1985, RECENT ADV EPILEPSY, V2
[13] MATTSON RH, 1986, ANN NEUROL, V20, P119
[14] CARBAMAZEPINE SIDE-EFFECTS IN CHILDREN AND ADULTS
PELLOCK, JM
[J]. EPILEPSIA, 1987, 28 : S64 - S70
[15] PELLOCK JM, 1989, PEDIATR CLIN N AM, V46, P435
[16] PELLOCK JM, IN PRESS PEDIATRIC E
[17] PRICK M, 1981, NEUROLOGY, V31, P398
[18] PRICK MJJ, 1972, CLINNEUROL NEUROSURG, V85, P67
[19] FATAL LIVER-FAILURE IN 16 CHILDREN WITH VALPROATE THERAPY
SCHEFFNER, D
KONIG, S
RAUTERBERGRULAND, I
KOCHEN, W
HOFMANN, WJ
UNKELBACH, S
[J]. EPILEPSIA, 1988, 29 (05) : 530 - 542
[20] SCHMIDT D, 1982, ADVERSE EFFECTS ANTI